Introducing Innovation
The UK is a major healthcare market. Getting into it takes more than a distributor.
The NHS is complex, fragmented and difficult to navigate. Success requires more than a product and a sales team — it requires access to the right people, an understanding of how decisions are made, and the credibility to build adoption.
We know how UK healthcare works.
Understand the NHS
We understand diagnostic pathways, laboratory operations, NHS priorities and the problems services are trying to solve.
Reach the right people
Our network and sector experience help us engage the clinical, operational and commercial decision-makers who matter.
Build the case
We translate product benefits into the clinical, operational and economic value UK healthcare organisations need to see.
Drive adoption
Through Progen Diagnostics, we provide the commercial presence and ongoing support needed to establish and grow technologies in the UK.
More than distribution. A route into UK healthcare.
Lifecycle's experience inside UK diagnostics gives Progen something a conventional distributor cannot easily replicate: a detailed understanding of the market, the people and the problems your technology needs to solve.
Technologies we want to bring to the UK.
We are actively looking for proven diagnostic technologies that solve real problems for UK healthcare — improving outcomes, increasing capacity, reducing cost or transforming the way services are delivered.
Cancer Diagnosis
Earlier, more accurate and less invasive diagnosis and surveillance.
Explore opportunity →Laboratory Automation
Sample transport, automated sample processing, storage and retrieval that reduce manual work and increase laboratory capacity.
Explore opportunity →Have something different?
These are our priority areas, not our boundaries. If your technology solves a significant problem in UK diagnostics, we want to hear about it.
Proof this model already works.
Our existing work demonstrates how diagnostic innovation can be positioned around the clinical problem it solves and the pathway to adoption in UK healthcare.
Uromonitor
A non-invasive, urine-based molecular test used in bladder cancer diagnosis and surveillance.
View the Uromonitor page →Diagnostics
healthcare